Nevertheless, to proceed towards clinical testing of the cardioprotective properties of CCN2, the concept of CCN2-engendered post-ischemic conditioning of the heart will have to be tested in vivo, and preferably in a large animal model more closely resembling acute myocardial infarction in human patients. The gene discussed is CCN2; the disease is myocardial infarction.